Perciliz Ahern is an experienced professional with a strong background in project management and laboratory operations within the biotechnology and pharmaceutical sectors. Currently serving as Director of CMC Vaccines at CSL Seqirus, Perciliz leads mRNA and cell culture platform technologies while overseeing strategic product development and portfolio management. Previous roles include Associate Director and Senior Manager in Technical Development project management at CSL Seqirus, as well as Research Program Manager and Senior Scientist at Rescindo Therapeutics Inc., where Perciliz was a founding scientist. Educational qualifications include a Ph.D. in Cell Biology from Duke University and a BS in Biological Sciences from the University of Notre Dame. Perciliz has extensive expertise in regulatory processes, project oversight, data analytics, and relationship management within scientific environments.
This person is not in the org chart
This person is not in any teams
This person is not in any offices